Prognostic factors for oral squamous cell carcinoma

被引：5

作者：

Eckert, A. W. ^{[1
]}

Lautner, M. H. W. ^{[1
]}

Dempf, R. ^{[1
]}

Schubert, J. ^{[1
]}

Bilkenroth, U. ^{[2
]}

机构：

[1] Univ Halle Wittenberg, Univ Klin & Poliklin Mund Kiefer & Plast Gesichts, D-06097 Halle, Germany

[2] Kreiskrankenhaus Eisleben, Inst Pathol, Lutherstadt Eisleben, Germany

来源：

CHIRURG | 2009年 / 80卷 / 02期

关键词：

Oral squamous cell carcinoma; Prognosis; Survival; Statistics; Therapy results; HEAD; CANCER; RADIOCHEMOTHERAPY; EPIDEMIOLOGY; RADIOTHERAPY;

D O I：

10.1007/s00104-008-1647-y

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The aim of the present study was to analyze different prognostic factors to calculate the overall survival in oral squamous cell carcinoma (OSCC). Samples retrospectively collected from 99 patients with primary OSCC were analyzed with regard to tumor node metastasis stage, grading, and 5-year survival time and summarized at an SPSS 11.0 databank. Treated were 72 men and 27 women (average age 59 years) due to oral squamous cell carcinoma. A general 5-year survival time of 57.3% was found. Patient survival depended on tumor size and the extent of lymph node metastasis: survival was 80.1% (n=23) for T1 tumors and only 16.2% (n=28) for T4 tumors, 68.7% (n=55) at the N0 stage and 42.8% at > N0 (n=44, chi(2) test P=0.01, Fischer's exact test P=0.014). Highly differentiated carcinomas (n=26) had a survival probability of 78.9% and G2 and G3 tumors of only 48.9% (n=73, chi(2) test P < 0.001). Tumor size and lymph node metastases are decisive.

引用

页码：138 / 143

页数：6

共 28 条

[1] Read all about it: The over-representation of breast cancer in popular magazines [J].

Blanchard, D ;

Erblich, J ;

Montgomery, GH ;

Bovbjerg, DH .

PREVENTIVE MEDICINE, 2002, 35 (04) :343-348

[2] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[3]

Bornstein Michael M, 2005, Schweiz Monatsschr Zahnmed, V115, P542

[4]

BOYLE JO, 1993, CANCER RES, V53, P4477

[5] Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan [J].

Chen, YK ;

Huang, HC ;

Lin, LM ;

Lin, CC .

ORAL ONCOLOGY, 1999, 35 (02) :173-179

[6] Oral malignant neoplasia: A survey of 428 cases in two Zimbabwean hospitals [J].

Chidzonga, MM .

ORAL ONCOLOGY, 2006, 42 (02) :177-183

[7] Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults [J].

Choi, KK ;

Kim, MJ ;

Yun, PY ;

Lee, JH ;

Moon, HS ;

Lee, TR ;

Myoung, H .

ORAL ONCOLOGY, 2006, 42 (02) :208-217

[8] Oral squamous cell carcinoma of the mandibular region: A survival study [J].

De Vicente, JC .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07) :536-543

[9] 31.Jahrestagung des DÖSAK, Justus-Liebig-Universität Gießen, 20.–21.11.2000Neue Studien zum Mundhöhlenkarzinom—Therapiekonzepte oder Prognosefaktoren? [J].

A. Eckardt .

Mund-, Kiefer- und Gesichtschirurgie, 2001, 5 (5) :323-325

[10] Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma, (OSCC):: A retrospective analysis of 207 patients [J].

Freier, Kolja ;

Engel, Michael ;

Lindel, Katja ;

Flechtenmacher, Christa ;

Muehling, Joachim ;

Hassfeld, Stefan ;

Hofele, Christof .

ORAL ONCOLOGY, 2008, 44 (02) :116-123

← 1 2 3 →